A detailed history of J. Safra Sarasin Holding Ag transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 15,503 shares of SRPT stock, worth $1.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
15,503
Previous 11,456 35.33%
Holding current value
$1.71 Million
Previous $1.81 Billion 6.97%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$124.33 - $156.75 $503,163 - $634,367
4,047 Added 35.33%
15,503 $1.94 Billion
Q2 2024

Jul 30, 2024

BUY
$113.33 - $163.85 $1.3 Million - $1.88 Million
11,456 New
11,456 $1.81 Billion

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.68B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.